Ping Loong - BLOOMAGE BIOTEC Insider

0963 -- Hong Kong Stock  

null 16.24  0.00  0.00%

Mr. Loong Ping Kwan is Company Secretary of Bloomage BioTechnology Corporationrationration Limited. Mr. Loong is a practicing solicitor admitted in Hong Kong and is a founder and a partner of Messrs. Loong and Yeung in Hong Kong. Messrs. Loong and Yeung is the legal advisers of the Company as to Hong Kong laws. Mr. Loong gained more than 21 year working experience in corporate finance merger and acquisition. Mr. Loong was an independent nonexecutive director of Minmetals Resources Limited from August 2009 to May 2012 whose shares are listed on the Main board of the Stock Exchange . He acted as the Company Secretary since May 2009.
Age: 49  Executive Since 2009      
86 10 8567 0099

Management Efficiency

The company has return on total asset (ROA) of 7.25 % which means that it generated profit of $7.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.14 % meaning that it generated $13.14 on every $100 dollars invested by stockholders.
The company has accumulated 99.22 M in total debt with debt to equity ratio (D/E) of 39.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BLOOMAGE BIOTEC has Current Ratio of 7.27 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives


Steven SareFast Retailing Co Ltd
Tokio OrikasaFast Retailing Co Ltd
Junsuke UsamiFast Retailing Co Ltd
Satoshi HataseFast Retailing Co Ltd
Hideaki TakadaFast Retailing Co Ltd
Serena PeckFast Retailing Co Ltd
Miyuki IsozakiFast Retailing Co Ltd
Justin KerrFast Retailing Co Ltd
Kunikazu KawasakiFast Retailing Co Ltd
Yasuyuki TerashiFast Retailing Co Ltd
Yoshihiro KuniiFast Retailing Co Ltd
Takuya JimboFast Retailing Co Ltd
Daisuke TsukagoshiFast Retailing Co Ltd
Takenari MotodaFast Retailing Co Ltd
Ivo VliegenFast Retailing Co Ltd
Alex GoldelmanFast Retailing Co Ltd
LeAnn NealzFast Retailing Co Ltd
Makoto HoketsuFast Retailing Co Ltd
AlishaFast Retailing Co Ltd
Jun YokohamaFast Retailing Co Ltd
Tandon DineshFast Retailing Co Ltd

Entity Summary

Bloomage BioTechnology Corporationration Limited, an investment holding company, develops, manufactures, and sells biochemical solutions in the People?s Republic of China, Asia, the Americas, and internationally. BLOOMAGE BIOTEC (0963) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Jinan, and employs 758 people.


Waiyan Yau, Financial Controller
Wen Hai, Non-Executive Independent Director
Lili Zhan, Independent Non-Executive Director
Zhaofeng Xue, Independent Non-Executive Director
Junhong Li, Independent Non-Executive Director
Anmin Gong, CFO
Guixin Xu, Vice General Manager - Bloomage Biopharm
Chunxi Wang, Vice General Manager - Bloomage Biopharm
Ning Hu, vice general manager of Beijing Bloomage Hyinc Technology Company Limited
Aihua Wang, Executive Director
Xueping Guo, Vice General Manager and Director - Bloomage Biopharm
Yihong Luan, vice general manager of Bloomage Biopharm
Xuekun Jin, CEO, Executive Director and Member of Remuneration Committee
Ping Loong, Company Secretary
Yan Zhao, Chairman
Jiajun Guo, Non-Executive Director
Aihua Liu, Executive Director and Member of Nomination Committee

Stock Performance Indicators

Current Sentiment - 0963

BLOOMAGE BIOTEC Investor Sentiment

Most of Macroaxis users are presently bullish on BLOOMAGE BIOTEC. What is your opinion about investing in BLOOMAGE BIOTEC? Are you bullish or bearish?
98% Bullish
2% Bearish

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also Trending Equities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.